Your session is about to expire
← Back to Search
Rock Steady Boxing for Parkinson's Disease
Study Summary
This trial evaluates a new exercise program for people with Parkinson's Disease to improve functional mobility, endurance, cardiovascular capacity, reaction time, quality of life, and reduce fear of falling.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am unable to complete health assessments.I am 18 years old or older.My Parkinson's Disease is between stages I and IV.I can complete all required health assessments.I am either male or female.
- Group 1: Rock Steady Boxing classes
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are being accepted for this medical research endeavor?
"Indeed, the trial is still recruiting patients as indicated by information published on clinicaltrials.gov. It was initially posted on March 7th 2023 and most recently updated 6 days later; 150 people are needed to run this study at a single medical centre."
Does this research trial include individuals of 45 years or older?
"This trial is open to applicants of 18 years or older, up until the age of one-hundred."
Are there still patient openings available for this research endeavor?
"This clinical trial is currently in search of participants, as reported on clinicaltrials.gov; the study was initially posted on March 7th 2023 and recently modified on March 6th 2023."
What prerequisites must be met to participate in this clinical test?
"This trial is seeking 150 individuals with a diagnosis of Parkinson's disease, aged between 18 and 100 years old. The primary eligibility requirements are gender (male or female) and Hoehn & Yahr stage from I to IV."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger